Comparing Acotiamide and Itopride for the Management of Indigestion

Inclusion Criteria * Patients experiencing bothersome post-prandial fullness or bothersome early satiation at least three days a week. * Symptom onset must have occurred six months prior to diagnosis, and symptoms must have been present for at least the past three months. * No evidence of organic, systemic, or metabolic disease based on clinical investigations and endoscopy. * Patients with co-existing symptoms of Epigastric Pain Syndrome (EPS) are included only if the symptoms causing the most distress are meal-related. * Individuals who have already tested negative for H. pylori (separate tests will not be conducted for the study). Exclusion Criteria * Patients with an identifiable organic disease that can explain their symptoms, such as peptic ulcer, GERD, or chronic pancreatitis. * Patients with a history of gastrointestinal surgery. * History of malignancy in the past five years. * Patients having major psychiatric or depressive disorders. * Patients with a history of drug or alcohol abuse. * Patients with advanced chronic kidney disease. * Patients with uncontrolled diabetes (HbA1c \>8). * Patients with uncontrolled hypertension. * Patients diagnosed with Irritable Bowel Syndrome. * Pregnant or lactating women. * Patients who have used antibiotics, opioids, or any other medication that -affects gastrointestinal function in the past 4 weeks. * H. pylori positive patients. * Patients who cannot fill out scales or record their symptoms.